BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4370878)

  • 1. [Detection of antibodies against Epstein's and Barr's virus in patients with carcinoma of the nasopharynx in the CSSR (author's transl)].
    Síbl O; Vonka V; Vlcková I; Závadová H
    Cas Lek Cesk; 1974 Oct; 113(42):1284-7. PubMed ID: 4370878
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of EB virus-specific IgA antibody from patients with nasopharyngeal carcinoma by immunoenzymic method (author's transl)].
    Liu YX; Zeng Y; Dong WP; Cao GR
    Zhonghua Zhong Liu Za Zhi; 1979; 1(1):8-12. PubMed ID: 233233
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of IgA serum antibodies to EB virus VCA in patients having survived nasopharyngeal cancer for over 15 years (author's transl)].
    Tang ZH
    Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):167-9. PubMed ID: 6286059
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-complement immunoperoxidase technique in the determination of EBNA antibody level in patients with nasopharyngeal carcinoma (author's transl)].
    Liu YX
    Zhonghua Zhong Liu Za Zhi; 1982 Feb; 4(1):20-2. PubMed ID: 6284464
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma.
    Hsu MM; Chiou JF; McCabe BF
    Ann Otol Rhinol Laryngol; 1974; 83(1):19-25. PubMed ID: 4359674
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous carcinoma of the nasopharynx.
    Moloy PJ; Chung YT; Krivitsky PB; Kim RC
    West J Med; 1985 Jul; 143(1):66-9. PubMed ID: 2994305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors.
    Henle W; Ho HC; Henle G; Kwan HC
    J Natl Cancer Inst; 1973 Aug; 51(2):361-9. PubMed ID: 4358130
    [No Abstract]   [Full Text] [Related]  

  • 9. Epstein-Barr virus-associated antibodies and serum biochemistry in nasopharyngeal carcinoma.
    Lynn TC; Hsieh RP; Chuang CY; Huang SC; Hsieh T; Tu SM
    Laryngoscope; 1984 Nov; 94(11 Pt 1):1485-8. PubMed ID: 6092804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on nasopharyngeal carcinoma in Thailand.
    Premabutr P; Thomson S; Srivatanakul P
    J Med Assoc Thai; 1974 Apr; 57(4):191-6. PubMed ID: 4377011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carcinomas of the nasopharynx. Relationship between histological type and anti-Epstein-Barr virus serology (author's transl)].
    Micheau C; de The G; Orofiamma B; Schwaab G; Brugere J; Tursz T; Sancho-Garnier H; Cachin Y
    Nouv Presse Med; 1980 Jan; 9(1):21-4. PubMed ID: 6243770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of tumor-virus associated antibodies by mixed hemadsorption.
    Gatti RA; Jonsson J
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:298. PubMed ID: 4368573
    [No Abstract]   [Full Text] [Related]  

  • 13. [The diagnosis of nasopharyngeal carcinoma (author's transl)].
    Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U
    HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphoepithelial carcinoma of the nasopharynx: a special tumor?].
    Meister P; Nathrath W; Wilmes E; Wolf H
    Verh Dtsch Ges Pathol; 1981; 65():171-5. PubMed ID: 6289547
    [No Abstract]   [Full Text] [Related]  

  • 15. [The cytotoxic effect of lymphocytes from patients with nasopharyngeal cancer (NPC) against a NPC epitheloid cell line (author's transl)].
    Lin YC; Chao WP; Liu CR; Hu RL; Zeng Y
    Zhonghua Zhong Liu Za Zhi; 1981 Feb; 3(1):1-4. PubMed ID: 6273085
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A modified 131 I immuno-autoradiographic method for detection of serum EB virus VCA-IgA antibody in nasopharyngeal carcinoma].
    Shang M
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):262-4. PubMed ID: 6299669
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nasopharyngeal cancer].
    Horiguchi S; Sawaki S
    Nihon Jibiinkoka Gakkai Kaiho; 1973 Jan; 76(1):86-7. PubMed ID: 4348039
    [No Abstract]   [Full Text] [Related]  

  • 20. [Present status of infectious mononucleosis and Epstein Barr virus].
    Ducroix JP; Smail A; Vovan AT; Devauchelle B; Baillet J
    LARC Med; 1984 Mar; 4(3):161-3. PubMed ID: 6325836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.